Antagonism of intense atracurium-induced neuromuscular block in children.

Antagonism of intense neuromuscular block induced by atracurium 0.5 mg kg-1 was attempted in four groups of six children using one of two doses of neostigmine (0.05 mg kg-1 and 0.1 mg kg-1) or of edrophonium (0.5 mg kg-1 and 1.0 mg kg-1) when the first twitch of the post-tetanic count (PTC1) was 10% of control. For comparison with normal practice, a fifth group received neostigmine 0.05 mg kg-1 when the first twitch of the train-of-four was 10% of control. Total recovery time from PTC1 10% to a train-of-four ratio of 0.8 was not reduced by early administration of the anticholinesterases, compared with conventional administration of neostigmine at T1 10%. However, recovery from intense block was faster after neostigmine than edrophonium (P less than 0.01). Doubling the doses of the anticholinesterases did not reduce the recovery time and had the effect of increasing variability. We conclude that there is no clinical advantage in attempting to antagonize intense neuromuscular block in children using normal or increased doses of neostigmine or edrophonium.

[1]  L. Skovgaard,et al.  Reversal of intense neuromuscular blockade following infusion of atracurium. , 1990, Anesthesiology.

[2]  L. Skovgaard,et al.  Clinical recovery and train-of-four ratio measured mechanically and electromyographically following atracurium. , 1989, Anesthesiology.

[3]  G. Meakin,et al.  Use of the post-tetanic count to monitor recovery from intense neuromuscular blockade in children. , 1988, British journal of anaesthesia.

[4]  G. Meakin,et al.  Comparison of atracurium-induced neuromuscular blockade in neonates, infants and children. , 1988, British journal of anaesthesia.

[5]  J. P. Payne,et al.  Antagonism of atracurium-induced neuromuscular blockade by neostigmine or edrophonium. , 1986, British journal of anaesthesia.

[6]  E. Robertson,et al.  Antagonism of profound neuromuscular blockade induced by vecuronium or atracurium. Comparison of neostigmine with edrophonium. , 1986, British journal of anaesthesia.

[7]  N. Harper,et al.  Antagonism of alcuronium with edrophonium or neostigmine. , 1984, British journal of anaesthesia.

[8]  Ronald D. Miller,et al.  NEOSTIGMINE ANTAGONIZES A PROFOUND NEUROMUSCULAR BLOCKADE MORE RAPIDLY THAN EDROPHONIUM , 1984 .

[9]  J. Williams,et al.  Recovery characteristics following antagonism of atracurium with neostigmine or edrophonium. , 1984, British journal of anaesthesia.

[10]  D. Bevan,et al.  Neostigmine and Edrophonium as Antagonists of Pancuronium in Infants and Children , 1983, Anesthesiology.

[11]  F. Donati,et al.  Twitch Depression and Train‐of–Four Ratio after Antagonism of Pancuronium with Edrophonium, Neostigmine, or Pyridostigmine , 1983, Anesthesia and analgesia.

[12]  D. R. Cook,et al.  Clinical pharmacology of atracurium in paediatric patients. , 1983, British journal of anaesthesia.

[13]  D. Bevan,et al.  Neostigmine, Pyridostigmine, and Edrophonium as Antagonists of Pancuronium , 1980, Anesthesiology.

[14]  Aaron F. Kopman Edrophonium Antagonism of Pancuronium‐induced Neuromuscular Blockade in Man: A Reappraisal , 1979, Anesthesiology.

[15]  L. Blaber,et al.  The mechanism of the facilitatory action of edrophonium in cat skeletal muscle , 1972, British journal of pharmacology.

[16]  H. H. Ali,et al.  Stimulus frequency in the detection of neuromuscular block in humans. , 1970, British journal of anaesthesia.

[17]  R. Katz Neuromuscular Effects of d-Tubocurarine, Edrophonium and Neostigmine in Man , 1967, Anesthesiology.